Break up NIH and NSF into 10+ bodies with fully independent approaches. Every 5-10 years, reassess their budgets. Hegemonic monoculture today very pernicious.
-
-
Like. Though we already have DOE, DOD, and other sources of funding so that experiment is already partially afoot? I like idea of a wide diversity of sources. Some light, fast, and private (yours!). Some gargantuan. Everything in between.
1 reply 0 retweets 4 likes -
DOE/DOD not that relevant for most scientists. And DOE budget dwarfed by NIH. Certainly better than nothing, yes. I think gargantuan funding institutions are bad because they force ecosystem to adapt to their preferences. (Not doing so is an irrational career strategy.)
1 reply 0 retweets 15 likes -
Relevance to most scientists I think less important than the scientific value of the efforts? (And hard to compare full-time government scientists at National Labs to university profs?) No gargantuan funding means no space program, no LHC, etc.? Hard to see how we avoid a mix.
1 reply 0 retweets 3 likes -
LHC some of the lowest-ROI science ever done! I’m not *against* funding it but it sure isn’t an example of a healthy funding ecosystem IMO.
4 replies 0 retweets 9 likes -
And do you agree that gargantuan efforts are sometimes necessary? LHC may be a bad example but of course even big bets are still bets and there seem to be many other good ones. I am for more heterogeneity and more $.
2 replies 0 retweets 1 like -
Yeah, a gargantuan effort towards fusion could be a huge deal. Or new vaccine approaches.
1 reply 0 retweets 1 like -
https://en.wikipedia.org/wiki/ITER is surely gargantuan? DOE estimates cost at $65B[1]. On vaccines, NIAID budget is about $6B/year[2]... $60B over ten years also seems somewhat gargantuan. [1] https://physicstoday.scitation.org/do/10.1063/PT.6.2.20180416a/full/ … [2]https://www.niaid.nih.gov/grants-contracts/budget-appropriation-fiscal-year-2020 …
2 replies 0 retweets 3 likes -
Replying to @patrickc @Noahpinion and
Point being: we spend *enormous* amounts of money today. But efficacy with which we do so seems quite poor. (We've discovered *one* broad-spectrum antiviral drug since Fauci took over NIAID 36(!!) years ago[1]. Is the problem really insufficient funding?) https://www.elsevier.es/es-revista-medicina-universitaria-304-articulo-history-progress-antiviral-drugs-from-S166557961500037X …
1 reply 0 retweets 5 likes -
Increasing funding is good. But the point is (usually) not to throw more money at the things we currently throw a lot of money at. It's to broaden the set of things we throw money at, and increase the number of people coming up with new and different approaches.
2 replies 0 retweets 13 likes

Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.